Energy expenditure regulation via macrophage migration inhibitory factor in obesity and in vitro anti-macrophage migration inhibitory factor effect of Alpinia officinarum Hance extraction

Endocrine Practice

Volumn 18, Issue 1, 2012, Pages 39-48

  Mirzaei, Khadijeh ^a,b   Hossein Nezhad, Arash ^a   Aslani, Shilan ^a   Emamgholipour, Solaleh ^a   Karimi, Mehrdad ^b   Keshavarz, Seyed ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALPINIA OFFICINARUM HANCE EXTRACT; ANTILIPEMIC AGENT; BETA ACTIN; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MACROPHAGE MIGRATION INHIBITION FACTOR; PLANT EXTRACT; RNA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ALPINIA OFFICINARUM; ARTICLE; BODY COMPOSITION; CALORIMETRY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; ENERGY EXPENDITURE; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84857595188     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP11116.OR     Document Type: Article

References (51)

1. Alvehus M, Burén J, Sjöström M, Goedecke J, Olsson T. The human visceral fat depot has a unique inflammatory profile. Obesity (Silver Spring). 2010;18:879-883.
2. Krinninger P, Brunner C, Ruiz P, et al. Role of the adipo-cyte-specific NF-kB activity in the regulation of IP-10 and T cell migration. Am J Physiol Endocrinol Metab. 2011; 300:E304-E311.
3. Aslani S, Hossein-nezhad A, Maghbooli Z, Mirzaei K, Karimi F. Genetic variation in macrophage migration inhibitory factor associated with gestational diabetes mel-litus and metabolic syndrome. Horm Metab Res. 2011;43: 557-561.
4. Kleemann R, Bucala R. Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associ-ated comorbidities. Mediators Inflamm. 2010:610479.
5. Grieb G, Merk M, Bernhagen J, Bucala R. Macrophage migration inhibitory factor (MIF): a promising biomarker. Drug News Perspect. 2010;23:257-264.
6. Herder C, Illig T, Baumert J, et al. Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Atherosclerosis. 2008;200:380-388.
7. Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol. 2003;3:791-800.
8. Kleemann R, Hausser A, Geiger G, et al. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature. 2000;408:211-216.
9. Harper JM, Wilkinson JE, Miller RA. Macrophage migration inhibitory factor-knockout mice are long lived and respond to caloric restriction. FASEB J. 2010;24: 2436-2442.
10. Ikeda D, Sakaue S, Kamigaki M, et al. Knockdown of macrophage migration inhibitory factor disrupts adipogen-esis in 3T3-L1 cells. Endocrinology. 2008;149:6037-6042.
11. Willeke P, Gaubitz M, Schotte H, et al. Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome. Arthritis Res Ther. 2007; 9:R43.
12. Lee J, Lee J, Jung E, et al. Ultraviolet A regulates adipo-genic differentiation of human adipose tissue-derived mes-enchymal stem cells via up-regulation of Kruppel-like fac-tor 2. J Biol Chem. 2010;285:32647-32656.
13. Salminen A, Kaarniranta K. Control of p53 and NF-?B signaling by WIP1 and MIF: Role in cellular senescence and organismal aging. Cell Signal. 2011;23:747-752.
14. Lee JH, Jung HS, Giang PM, et al. Blockade of nuclear factor-kappaB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera. J Pharmacol Exp Ther. 2006;316:271-278.
15. Selvaraj D, Sarma RK, Sathishkumar R. Phylogenetic analysis of chloroplast matK gene from Zingiberaceae for plant DNA barcoding. Bioinformation. 2008;3:24-27.
16. Shin D, Kinoshita K, Koyama K, Takahashi K. Antiemetic principles of Alpinia officinarum. J Nat Prod. 2002;65:1315-1318.
17. Seddeag M, Madawe G, El Badwi S, Bakhiet A. The effect of dietary Alpinia officinarum (Hance) supplementation in Bovns-type chicks. Int J Poultry Sci. 2010;9:499-502.
18. Jung B, Shin M. Illustrated Encyclopedia of Korean Medicinal Plants. 1st ed. Seoul, Korea: Younglim Press, 1990: 250-251.
19. Heo MY, Sohn SJ, Au WW. Anti-genotoxicity of galan-gin as cancer chemopreventive agent candidate. Mutat Res. 2001;488:135-150.
20. Kang S, Kim J, Son K, HP. K, Chang H. Isolation of COX-2 inhibitors from Alpinia officinarum. Korean J. Pharmacognosy. 2000;31:57-62.
21. Kim YU, Son HK, Song HK, Ahn MJ, Lee SS, Lee SK. Inhibition of 5alpha-reductase activity by diarylheptanoids from Alpinia officinarum. Planta Medica. 2003;69:72-74.
22. Ly TN, Yamauchi R, Shimoyamada M, Kato K. Isolation and structural elucidation of some glycosides from the rhi-zomes of smaller galanga (Alpinia officinarum Hance). J Agric Food Chem. 2002;50:4919-4924.
23. Iwashita K, Yamaki K, Tsushida T. Mioga (Zingiber mioga Rosc.) Extract prevents 3T3-L1 differentiation into adipocytes and obesity in mice. Food Sci Technol Res. 2001;7:164-170.
24. Shi G, An LJ, Jiang B, Guan S, Bao YM. Alpinia pro-tocatechuic acid protects against oxidative damage in vitro and reduces oxidative stress in vivo. Neurosci Lett. 2006;403:206-210.
25. Israf DA, Khaizurin TA, Syahida A, Lajis NH, Khozirah S. Cardamonin inhibits COX and iNOS expres-sion via inhibition of p65NF-kappaB nuclear translocation and Ikappa-B phosphorylation in RAW 264.7 macrophage cells. Mol Immunol. 2007;44:673-679.
26. Bendjeddou D, Lalaoui K, Satta D. Immunostimulating activity of the hot water-soluble polysaccharide extracts of Anacyclus pyrethrum, Alpinia galanga, and Citrullus colo-cynthis. J Ethnopharmacol. 2003;88:155-160.
27. Lee CC, Houghton P. Cytotoxicity of plants from Malaysia and Thailand used traditionally to treat cancer. J Ethnopharmacol. 2005;100:237-243.
28. Xia DZ, Yu XF, Wang HM, Ren QY, Chen BM. Anti-obesity and hypolipidemic effects of ethanolic extract from Alpinia officinarum Hance (Zingiberaceae) in rats fed high-fat diet. J Med Food. 2010;13:785-791.
29. Chou YC, Wang SY, Chen GC, Lin YS, Chao PM. The functional assessment of Alpinia pricei on metabolic syn-drome induced by sucrose-containing drinking water in mice. Phytother Res. 2009;23:558-563.
30. Mirzaei K, Hossein-Nezhad A, Chamari M, Shahbazi S. Evidence of a role of ANGPTL6 in resting metabolic rate and its potential application in treatment of obesity. Minerva Endocrinol. 2011;36:13-21.
31. Aslani S, Hossein-nezhad A, Maghbooli Z, Mirzaei K, Karimi F. Genetic variation in macrophage migration inhibitory factor associated with gestational diabetes mel-litus and metabolic syndrome. Horm Metab Res. 2001; 43:557-561.
32. Tereshchenko IP, Petrkova J, Mrazek F, et al. The macrophage migration inhibitory factor (MIF) gene poly-morphism in Czech and Russian patients with myocardial infarction. Clin Chim Acta. 2009;402:199-202.
33. Hossein-nezhad K, Mirzaei S, Aslani A, Tootee A, Karimi F. MIF expression in induced peripheral blood mononuclear cells by vitamin D3 and its potential correla-tion with resting metabolic rate in obesity. Eur J Inflamm. 2011;9:125-134.
34. Hossein-nezhad A, Ahangari Gh, Larijani B. Evaluating of VDR gene variation and its interaction with immune reg-ulatory molecules in osteoporosis. Iranian J Publ Health. 2009;38:27-36.
35. Dandona P, Aljada A, Ghanim H, et al. Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. J Clin Endocrinol Metab. 2004;89:5043-5047.
36. Sakaue S, Ishimaru S, Hizawa N, et al. Promoter poly-morphism in the macrophage migration inhibitory fac-tor gene is associated with obesity. Int J Obes (Lond). 2006;30:238-242.
37. Herder C, Klopp N, Baumert J, et al. Effect of macro-phage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002. Diabetologia. 2008;51:276-284.
38. Toso C, Emamaullee JA, Merani S, Shapiro AM. The role of macrophage migration inhibitory factor on glu-cose metabolism and diabetes. Diabetologia. 2008;51: 1937-1946.
39. Church TS, Willis MS, Priest EL, et al. Obesity, mac-rophage migration inhibitory factor, and weight loss. Int J Obes. 2005;29:675-681.
40. Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation. 2004;110: 1564-1571.
41. Sheu WH, Chang TM, Lee WJ, et al. Effect of weight loss on proinflammatory state of mononuclear cells in obese women. Obesity (Silver Spring). 2008;16:1033-1038.
42. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspec-tive based on interactions between obesity, diabetes, and inflammation. Circulation. 2005;111:1448-1454.
43. Skurk T, Herder C, Kräft I, Müller-Scholze S, Hauner H, Kolb H. Production and release of macrophage migration inhibitory factor from human adipocytes. Endocrinology. 2005;146:1006-1011.
44. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821-1830.
45. Akyildiz M, Gunsar F, Nart D, et al. Macrophage migra-tion inhibitory factor expression and MIF gene -173 G/C polymorphism in nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2010;22:192-198.
46. Hseu YC, Chen CS, Wang SY. Alpinia pricei rhizome extracts induce cell cycle arrest in human squamous car-cinoma KB cells and suppress tumor growth in nude mice. Evid Based Complement Alternat Med. 2009 [Epub ahead of print].
47. Tawfik Amin A, Shiraishi N, Ninomiya S, Tajima M, Inomata M, Kitano S. Activation of nuclear factor kappa B and induction of migration inhibitory factor in tumors by surgical stress of laparotomy versus carbon dioxide pneumoperitoneum: an animal experiment. Surg Endosc. 2010;24:578-583.
48. Mitchell RA, Bucala R. Tumor growth-promoting prop-erties of macrophage migration inhibitory factor (MIF). Semin Cancer Biol. 2000;10:359-366.
49. Lin CT, Senthil Kumar KJ, Tseng YH, et al. Anti-inflammatory activity of Flavokawain B from Alpinia pri-cei Hayata. J Agric Food Chem. 2009;57:6060-6065.
50. Hayden MS, Ghosh S. Signaling to NF-kappa B. Genes Dev. 2004;18:2195-2224.
51. Roubenoff R. Sarcopenic obesity: does muscle loss cause fat gain? Lessons from rheumatoid arthritis and osteoarthri-tis. Ann N Y Acad Sci. 2000;904:553-557.